Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress

2021 ◽  
Author(s):  
Kanishk Luhach ◽  
Giriraj T. Kulkarni ◽  
Vijay P. Singh ◽  
Bhupesh Sharma
2019 ◽  
Vol 10 (4) ◽  
pp. 3440-3448
Author(s):  
Osama Q. Fadhil ◽  
Waleed K. Abdulsahib ◽  
Hussam H.Tizkam ◽  
Faruk H. AL-Jawad

Epilepsy is a standout amongst the most widely recognized genuine mind issue, can happen at all ages and have numerous potential causes. Epilepsy takes place because of a wide range of cell or biochemical changes, for example, modifications in particle channels work, synapse level (excitatory and inhibitory), synapse receptor work, vitality digestion and oxidative stress. This study was performed to explore the possible antiepileptic effect of Melatonin against pilocarpine-induced seizure in male rats. The research was carried out on (40) healthy male Wister rats weighing between 200-300 gm; they were equally allocated to four groups (10 rats in each group).Group (1) normal group (not received any drug), Group (2) negative control group (received only pilocarpine during induction of seizure, Group (3) positive control group (Valproic acid group received 20 mg/kg orally twice daily) and Group (4) Melatonin group (3 mg/kg received orally once a day).Rats of each group (except normal group) were injected intraperitoneal with pilocarpine hydrochloride (400 mg/kg) after 21 days of tested drugs administered orally. The mean onset and duration of seizure were determined to evaluate the efficacy of tested drugs and to compare these effect with that of the normal group and Valproic acid group. Besides, the mean of onset and duration of seizure, neuroprotective effect (Neu N), NMDA receptor, Sodium channels were measured in all groups after convulsion had been induced to detect the effects of the tested drugs on these parameters by comparing them with normal, negative and positive groups. Melatonin had a preventive and anticonvulsant effect against pilocarpine-induced seizure in rats due to decreasing the onset and severity of seizure this effect may be by blocking sodium channels and NMDA receptor also Melatonin had a neuroprotective effect by preventing damage to neurons this effect by decreasing the inflammation and oxidative stress.


2019 ◽  
Vol 33 (S1) ◽  
Author(s):  
Jordan M. Lee ◽  
Vasanthi R. Sunil ◽  
Kinal Vayas ◽  
Alexa Murray ◽  
Alessandro Venosa ◽  
...  

2017 ◽  
Vol 179 (1) ◽  
pp. 102-109 ◽  
Author(s):  
Nematollah Ahangar ◽  
Maloos Naderi ◽  
Abdolali Noroozi ◽  
Maryam Ghasemi ◽  
Ehsan Zamani ◽  
...  

2016 ◽  
Vol 95 ◽  
pp. 159-167 ◽  
Author(s):  
Giovana M. Ourique ◽  
Etiane M.H. Saccol ◽  
Tanise S. Pês ◽  
Werner G. Glanzner ◽  
Sun Hee Schiefelbein ◽  
...  

2010 ◽  
Vol 118 (2) ◽  
pp. 501-509 ◽  
Author(s):  
Tony K. L. Kiang ◽  
Xiao Wei Teng ◽  
Stoyan Karagiozov ◽  
Jayakumar Surendradoss ◽  
Thomas K. H. Chang ◽  
...  

2020 ◽  
Vol 97 (5) ◽  
pp. 314-323 ◽  
Author(s):  
Zhibo Gai ◽  
Evelin Krajnc ◽  
Sophia L. Samodelov ◽  
Michele Visentin ◽  
Gerd A. Kullak-Ublick

Medicina ◽  
2020 ◽  
Vol 56 (6) ◽  
pp. 267
Author(s):  
Radu Lefter ◽  
Alin Ciobica ◽  
Iulia Antioch ◽  
Daniela Carmen Ababei ◽  
Luminita Hritcu ◽  
...  

Background and objectives: The hormone oxytocin (OXT) has already been reported in both human and animal studies for its promising therapeutic potential in autism spectrum disorder (ASD), but the comparative effectiveness of various administration routes, whether central or peripheral has been insufficiently studied. In the present study, we examined the effects of intranasal (IN) vs. intraperitoneal (IP) oxytocin in a valproic-acid (VPA) autistic rat model, focusing on cognitive and mood behavioral disturbances, gastrointestinal transit and central oxidative stress status. Materials and Methods: VPA prenatally-exposed rats (500 mg/kg; age 90 days) in small groups of 5 (n = 20 total) were given OXT by IP injection (10 mg/kg) for 8 days consecutively or by an adapted IN pipetting protocol (12 IU/kg, 20 μL/day) for 4 consecutive days. Behavioral tests were performed during the last three days of OXT treatment, and OXT was administrated 20 minutes before each behavioral testing for each rat. Biochemical determination of oxidative stress markers in the temporal area included superoxide dismutase (SOD), glutathione peroxidase (GPx) and malondialdehyde (MDA). A brief quantitative assessment of fecal discharge over a period of 24 hours was performed at the end of the OXT treatment to determine differences in intestinal transit. Results: OXT improved behavioral and oxidative stress status in both routes of administration, but IN treatment had significantly better outcome in improving short-term memory, alleviating depressive manifestations and mitigating lipid peroxidation in the temporal lobes. Significant correlations were also found between behavioral parameters and oxidative stress status in rats after OXT administration. The quantitative evaluation of the gastrointestinal (GI) transit indicated lower fecal pellet counts in the VPA group and homogenous average values for the control and both OXT treated groups. Conclusions: The data from the present study suggest OXT IN administration to be more efficient than IP injections in alleviating autistic cognitive and mood dysfunctions in a VPA-induced rat model. OXT effects on the cognitive and mood behavior of autistic rats may be associated with its effects on oxidative stress. Additionally, present results provide preliminary evidence that OXT may have a balancing effect on gastrointestinal motility.


Nephrology ◽  
2018 ◽  
Vol 23 (4) ◽  
pp. 351-361 ◽  
Author(s):  
Reza Heidari ◽  
Faezeh Jafari ◽  
Forouzan Khodaei ◽  
Babak Shirazi Yeganeh ◽  
Hossein Niknahad

Sign in / Sign up

Export Citation Format

Share Document